Meticulous Research® forecasts the ELISA market to grow to $32.69 billion by 2031, at a CAGR of 6.1% from 2024 to 2031. This growth is driven by increasing chronic and infectious diseases, technological advancements, and broader applications of ELISA in clinical and food industries. However, issues like potential false positives and high antibody preparation costs are potential barriers.
Growth Opportunities and Challenges
The market is expected to benefit from expanding research in developing regions, advancements in biomarker research, and increased focus on vaccine development. Challenges include stringent regulations and the presence of alternative diagnostic technologies.
